You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker

Article info

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker

Authors

  • Bingxi He School of Electronic Electrical and Communication Engineering, University of the Chinese Academy of Sciences, Beijing, China CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Di Dong CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China School of Artificial Intelligence, University of the Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Yunlang She Department of Thoracic Surgery, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China PubMed articlesGoogle scholar articles
  • Caicun Zhou Department of Medical Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shang hai, China PubMed articlesGoogle scholar articles
  • Mengjie Fang CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Yongbei Zhu CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine and Engineering, Beihang University, Beijing, China PubMed articlesGoogle scholar articles
  • Henghui Zhang Department of Medicine, Beijing Genecast Biotechnology Co, Beijing, China PubMed articlesGoogle scholar articles
  • Zhipei Huang School of Electronic Electrical and Communication Engineering, University of the Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Tao Jiang Department of Medical Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shang hai, China PubMed articlesGoogle scholar articles
  • Jie Tian CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine and Engineering, Beihang University, Beijing, China Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, China Key Laboratory of Big Data-Based Precision Medicine (Beihang University), Ministry of Industry and Information Technology, Beijing, China PubMed articlesGoogle scholar articles
  • Chang Chen Department of Thoracic Surgery, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China PubMed articlesGoogle scholar articles

Citation

He B, Dong D, She Y, et al
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
Journal for ImmunoTherapy of Cancer 2020;8:e000550. doi: 10.1136/jitc-2020-000550
Online issue publication 
July 06, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.